Cargando…

Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population‐Based Cohort Study

BACKGROUND: Recent studies have reported that dihydropyridine calcium channel blockers (dCCBs) may increase the risk of pancreatic cancer, but these studies had methodological limitations. We thus aimed to determine whether dCCBs are associated with an increased risk of pancreatic cancer compared wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rouette, Julie, McDonald, Emily G., Schuster, Tibor, Brophy, James M., Azoulay, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798809/ https://www.ncbi.nlm.nih.gov/pubmed/36515246 http://dx.doi.org/10.1161/JAHA.122.026789

Ejemplares similares

Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study
por: Rouette, Julie, et al.
Publicado: (2022)

Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
por: Mendez, Sean R., et al.
Publicado: (2021)

Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor
por: Wang, Bin, et al.
Publicado: (2022)

The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
por: Takayama, Makoto, et al.
Publicado: (2009)

Quantitative Structure-Activity Relationship Studies of 4-Imidazolyl- 1,4-dihydropyridines as Calcium Channel Blockers
por: Hadizadeh, Farzin, et al.
Publicado: (2013)

A New Generation of Dihydropyridine Calcium Channel Blockers: Photostabilization of Liquid Formulations Using Nonionic Surfactants
por: Ioele, Giuseppina, et al.
Publicado: (2019)

Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1
por: Pan, Xiaohui, et al.
Publicado: (2021)

Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk
por: Haller, H
Publicado: (2008)

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension
por: Tocci, Giuliano, et al.
Publicado: (2017)

Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta‐analysis
por: Liang, Ling, et al.
Publicado: (2022)

Risk of Myocardial Infarction With Combination Antihypertensive Regimens Including a Dihydropyridine Calcium Channel Blocker in Hypertensive Diabetics
por: Anderson, Robert J., et al.
Publicado: (2003)

Dihydropyridine calcium blockers do not interfere with non-rapid eye movement sleep
por: Han, GoEun, et al.
Publicado: (2022)

A(2B) adenosine receptor inhibition by the dihydropyridine calcium channel blocker nifedipine involves colonic fluid secretion
por: Asano, Teita, et al.
Publicado: (2020)

The dihydropyridine-sensitive calcium channel subtype in cone photoreceptors
Publicado: (1996)

Nonmodal gating of cardiac calcium channels as revealed by dihydropyridines
Publicado: (1989)

Chronic Kidney Disease Progression Risk in Patients With Diabetes Mellitus Using Dihydropyridine Calcium Channel Blockers: A Nationwide, Population-Based, Propensity Score Matching Cohort Study
por: Lin, Shih-Yi, et al.
Publicado: (2022)

Internal and external effects of dihydropyridines in the calcium channel of skeletal muscle
Publicado: (1990)

Calcium-dependent inactivation of the dihydropyridine-sensitive calcium channels in GH3 cells
Publicado: (1988)

Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells
por: Zou, Jun, et al.
Publicado: (2012)

Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer
por: Principe, Daniel R., et al.
Publicado: (2022)

Effect of Dihydropyridine Calcium Channel Blocker on Mortality of Hypertension Patients With Moderate-Severe Pulmonary Acute Respiratory Distress Syndrome: A Multicenter Retrospective Observational Cohort Study
por: Li, Fengyuan, et al.
Publicado: (2021)

Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor
Publicado: (1989)

Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS
por: Toal, Corey B., et al.
Publicado: (2012)

Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium
Publicado: (1991)

Modulation of calcium channels in arterial smooth muscle cells by dihydropyridine enantiomers
Publicado: (1993)

Calcium Channel Blocker Overdose Treated with Calcium Resulting in Pancreatitis: A Case Report
por: Khan, Salman, et al.
Publicado: (2019)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Fast activation of dihydropyridine-sensitive calcium channels of skeletal muscle. Multiple pathways of channel gating
Publicado: (1996)

Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
por: Zhou, Yi-Ting, et al.
Publicado: (2013)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Negative surface charge density near heart calcium channels. Relevance to block by dihydropyridines
Publicado: (1987)

A Dihydropyridine-sensitive Voltage-dependent Calcium Channel in the Sarcolemmal Membrane of Crustacean Muscle
por: Erxleben, Christian, et al.
Publicado: (1997)

Novel 1, 4-dihydropyridines for L-type calcium channel as antagonists for cadmium toxicity
por: Saddala, Madhu Sudhana, et al.
Publicado: (2017)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_biu8i0h7tg2i2nme07597uakr4